Search Results

You are looking at 1 - 10 of 171 items for :

  • All content x
Clear All
Full access

Zhubin J. Gahvari, Michael Lasarev, Jens C. Eickhoff, Aric C. Hall, Peiman Hematti, Mark B. Juckett, Vaishalee P. Kenkre, and Natalie S. Callander

Background: Obesity, and in particular severe obesity, is increasingly prevalent in the United States. Epidemiological studies have shown an association in multiple myeloma (MM) between obesity and mortality (Teras et al, Br J Haematol 2014

Full access

Philip J. Saylor and Matthew R. Smith

This article presents a focused summary of the scope and severity of the metabolic and skeletal adverse effects of androgen deprivation, with particular focus on obesity and sarcopenia, insulin resistance and diabetes, cardiovascular disease, and

Full access

Marwah W. Farooqui, Caitlin Carter, Nicholas Gustafson, Saherish Abbasi, Sravani Sagireddy, Kathryn Hockensmith, Amy Stein, Masood Ghouse, and Krishan Srinivasan

Obesity has an association with triple negative breast cancer (TNBC). Healthy diet, weight loss, and exercise have lead to favorable outcomes (overall survival [OS], progression free survival [PFS],quality of life [QOL])in TNBC. We aim to highlight

Full access

Eleni Linos and Walter C. Willett

. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults . JAMA 2003 ; 348 : 1625 – 1638 . 7. Huang Z Hankinson SE Colditz GA . Dual effects of weight and weight gain on breast cancer risk . JAMA 1997

Full access

Qiuxia Cui, Dan Zhang, Xing Liao, Jianing Tang, Deguang Kong, Qian Yang, Yan Gong, and Gaosong Wu

Background: Recent decades have discovered evidences that obesity is associated with a higher risk of developing breast cancer both in women and men, and even with worse disease outcome. Although the development of breast cancer was proved linked

Full access

Carlo C. Maley and Anil K. Rustgi

. Association between body mass and adenocarcinoma of the esophagus and gastric cardia . Ann Intern Med 1999 ; 130 : 883 – 890 . 61. Vaughan TL Davis S Kristal A . Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and

Full access

Samuel Martel, Matteo Lambertini, Dominique Agbor-Tarh, Noam F. Ponde, Andrea Gombos, Vicki Paterson, Florentine Hilbers, Larissa Korde, Anna Manukyants, Amylou Dueck, Christian Maurer, Martine Piccart, Alvaro Moreno-Aspitia, Christine Desmedt, Serena Di Cosimo, and Evandro de Azambuja

Background The burden of obesity is significant, with an estimated prevalence of 12.0% among adults worldwide. 1 The prevalence of obesity is even higher among cancer survivors, 2 and the annual increase is greater among survivors of breast cancer

Full access

Michael B. Streiff, Bjorn Holmstrom, Aneel Ashrani, Paula L. Bockenstedt, Carolyn Chesney, Charles Eby, John Fanikos, Randolph B. Fenninger, Annemarie E. Fogerty, Shuwei Gao, Samuel Z. Goldhaber, Paul Hendrie, Nicole Kuderer, Alfred Lee, Jason T. Lee, Mirjana Lovrincevic, Michael M. Millenson, Anne T. Neff, Thomas L. Ortel, Rita Paschal, Sanford Shattil, Tanya Siddiqi, Kristi J. Smock, Gerald Soff, Tzu-Fei Wang, Gary C. Yee, Anaadriana Zakarija, Nicole McMillian, and Anita M. Engh

NCCN.org ). Obesity is common among patients with cancer and increases the risk of VTE 12 , 13 ; therefore, these NCCN Guidelines Insights focus on a notable addition to the 2015 NCCN Cancer-Associated Venous Thromboembolic Disease Guidelines

Full access

Chunkit Fung, Paul C. Dinh Jr, Sophie D. Fossa, and Lois B. Travis

multi-institutional study of 1,214 TCS after cisplatin-based chemotherapy reported that 26% and 3.9% of TCS have obesity, with respective body mass indexes of 30 to 39 and ≥40 kg/m 2 , which is a significant CVD risk factor. 36 Mortality TCS may have

Full access

Mohammad Abu Zaid, Wambui G. Gathirua-Mwangi, Chunkit Fung, Patrick O. Monahan, Omar El-Charif, Annalynn M. Williams, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Clair J. Beard, Ryan Cook, Sandra K. Althouse, Shirin Ardeshir-Rouhani-Fard, Paul C. Dinh Jr, Howard D. Sesso, Lawrence H. Einhorn, Sophie D. Fossa, Lois B. Travis, and for the Platinum Study Group

triglyceride levels, decreased high-density lipoprotein (HDL) cholesterol levels, and obesity. 14 Using various definitions, European studies of TCS have reported a wide variation in the prevalence of MetS, ranging from 13% to 39%. 15 – 19 Some investigations